World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Kojima K, Watanabe K, Kawai M, Yagi S, Kaku K, Ikenouchi M, Sato T, Kamikozuru K, Yokoyama Y, Takagawa T, Shimizu M, Shinzaki S. Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis. World J Gastroenterol 2024; 30(13): 1871-1886 [PMID: 38659488 DOI: 10.3748/wjg.v30.i13.1871]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i13/1871.htm

(149) (156) (0) (0) (0) (6) (1) (7222) (14)

Number	Citing Articles
1	Sara R Lopes, Claudio Martins, Madalena Teixeira, David Tomás. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis. World Journal of Gastroenterology 2024; 30(34): 3929-3931 doi: 10.3748/wjg.v30.i34.3929 Abstract(614) \| Core Tip(621) \| Full Article(HTML)(2082) \| Full Article (PDF)-338K(204) \| Full Article with Cover (PDF)-563K(128) \| Full Article (XML)-34K(138) \| Audio-100K(46) \| Peer-Review Report-223K(115) \| Answering Reviewers-43K(119) \| Times Cited (0) \| Total Visits (2552) \| Open
2	Tofacitinib. Reactions Weekly 2024; 2007(1) doi: 10.1007/s40278-024-58881-4
3	Choon Jin Ooi, Khoon Lin Ling, Julajak Limsrivilai, Shu‐Chen Wei, Joyce Wing Yan Mak, Taku Kobayashi, Luan Minh Dang, Rupert W. Leong, Huiyu Lin, Meng‐Tzu Weng, Wan Chee Ong, Vineet Ahuja, Satimai Aniwan, Ryota Hokari, Wei Jie Jonathan Lee, Alex Hwong‐Ruey Leow, Wai‐Keung Leung, Wee‐Chian Lim, Govind Makharia, Katsuyoshi Matsuoka, Nazri Mustaffa, Siew‐Chien Ng, Mathew Philip, Pises Pisespongsa, Raja Affendi Raja Ali, Zhi Hua Ran, Marcellus Simadibrata, Jose Sollano, Malcolm Tan, Hang Dao Viet, Nik Razima Wan Ibrahim, Kai Chun Wu, Byong Duk Ye, Ida Hilmi. Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL‐23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease. Journal of Gastroenterology and Hepatology 2026; doi: 10.1111/jgh.70379
4	Akira Nogami, Kunio Asonuma, Shinji Okabayashi, Maiko Ikenouchi, Takahisa Matsuda, Shinichiro Shinzaki, Masayuki Fukata, Taku Kobayashi. Real‐World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study. United European Gastroenterology Journal 2024; 12(10) doi: 10.1002/ueg2.12704
5	Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment option. World Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386 Abstract(601) \| Core Tip(671) \| Full Article(HTML)(2557) \| Full Article (PDF)-461K(180) \| Full Article with Cover (PDF)-796K(148) \| Full Article (XML)-92K(143) \| Audio-1114K(22) \| Peer-Review Report-175K(109) \| Answering Reviewers-254K(94) \| Times Cited (0) \| Total Visits (3489) \| Open
6	Javier P Gisbert, María Chaparro. Janus Kinase Inhibitors for Inflammatory Bowel Disease: Concise Questions and Answers on Their Use in Clinical Practice. Inflammatory Bowel Diseases 2026; 32(4) doi: 10.1093/ibd/izaf273
7	Yuki Itoi, Yu Hashimoto, Takashige Masuo, Tomoyuki Masuda, Kyoko Marubashi, Atsuo Iwamoto, Masanori Sekiguchi, Kazuhiro Takahashi, Yuko Kimura, Yoko Hachisu, Shota Tomaru, Keigo Sato, Hirohito Tanaka, Hiroko Hosaka, Shiko Kuribayashi, Yoji Takeuchi, Toshio Uraoka. Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study. Cureus 2025; doi: 10.7759/cureus.97500
8	Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, Sara Concetta Schiavone, Stefano Migliozzi, Livia Biancone. Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis. Journal of Clinical Medicine 2024; 13(23) doi: 10.3390/jcm13237186
9	Soichi Yagi, Hirokazu Fukui, Maiko Ikenouchi, Tetsuya Shiraishi, Koji Kaku, Midori Wakita, Yasuhiro Takagi, Toshiyuki Sato, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Tetsuya Takagawa, Toshihiko Tomita, Shinichiro Shinzaki. Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis. Journal of Clinical Medicine 2025; 14(1) doi: 10.3390/jcm14010217
10	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(816) \| Core Tip(834) \| Full Article(HTML)(1760) \| Full Article (PDF)-410K(153) \| Full Article with Cover (PDF)-639K(208) \| Full Article (XML)-117K(128) \| Audio-785K(15) \| Peer-Review Report-230K(122) \| Answering Reviewers-209K(128) \| Times Cited (0) \| Total Visits (2249) \| Open
11	Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942 Abstract(643) \| Core Tip(727) \| Full Article(HTML)(3911) \| Full Article (PDF)-2682K(313) \| Full Article with Cover (PDF)-2954K(195) \| Full Article (XML)-189K(137) \| Audio-1388K(25) \| Peer-Review Report-220K(135) \| Answering Reviewers-74K(118) \| Times Cited (0) \| Total Visits (5537) \| Open
12	D. I. Trukhan. Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects. Meditsinskiy sovet = Medical Council 2024; (15) doi: 10.21518/ms2024-344
13	Yunseok Choi, Suhyun Lee, Hyeon Ji Kim, Taemin Park, Won Gun Kwack, Seungwon Yang, Eun Kyoung Chung. State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review. Pharmaceuticals 2025; 18(5) doi: 10.3390/ph18050740
14	Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro, Sandro da Costa Ferreira, Munique Kurtz de Mello, Matheus Freitas Cardoso de Azevedo, Aderson Omar Mourão Cintra Damião, Alexandre de Sousa Carlos, Luísa Leite Barros, Maria Luiza Queiroz de Miranda, Andrea Vieira, Marcos Paulo Moraes Sales, Gilmara Pandolfo Zabot, Ornella Sari Cassol, Antonio José Tiburcio Alves, Márcio Lubini, Marta Brenner Machado, Cristina Flores, Fabio Vieira Teixeira, Claudio Saddy Rodrigues Coy, Cyrla Zaltman, Liliana Andrade Chebli, Ligia Yukie Sassaki, Omar Féres, Júlio Maria Fonseca Chebli. Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03656-x

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.